###begin article-title 0
Alterations of GPI transamidase subunits in head and neck squamous carcinoma
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 75 87 75 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIG-T </italic>
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
GPI anchor attachment is catalyzed by the GPI transamidase (GPIT) complex. GAA1, PIG-T and PIG-U are the three of five GPIT subunits. Previous studies demonstrated amplification and overexpression of GPIT subunits in bladder and breast cancer with oncogenic function. We performed an analysis of these subunits in head and neck squamous cell carcinoma (HNSCC).
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 12 24 12 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIG-T </italic>
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 512 529 512 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mann-Whitney test</italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 704 719 704 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(paired t-test)</italic>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
To evaluate GAA1, PIG-T and PIG-U in HNSCC, we used quantitative PCR (QPCR) and quantitative RT-PCR (QRT-PCR) to determine the copy number of those genes in primary tumors and the matching lymphocytes in 28 patients with HNSCC and quantified RNA expression of those genes in 16 primary HNSCC patients and 4 normal control tissue samples. GAA1 showed a significant increase in normalized mRNA expression, 2.11 (95% CI: 1.43, 2.79), in comparison to that of normal controls, 0.43 (95% CI: -0.76, 1.61), p = 0.014 (Mann-Whitney test). The mean genomic copy number of GAA1 was significantly increased in HNSCC, 0.59 (95% CI: 0.50, 0.79), in comparison to lymphocyte DNA, 0.35 (95% CI: 0.30, 0.50), p = 0.001 (paired t-test).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
An increased expression level and elevated copy number for GAA1 suggest a role for this GPI anchor subunit in HNSCC.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
HNSCC has an annual incidence of over than 40,000 cases per year in United States and is characterized by local tumor aggressiveness, a high rate of early recurrences, and development of second primary carcinomas [1]. Despite modern therapeutic strategies, overall 5-year survival rate does have only modestly improved.
###end p 9
###begin p 10
###xml 249 351 249 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phosphatidylinositol Glycan Class U (PIG-U), Glycosylphosphatidylinositol Anchor Attachment Protein 1 </italic>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 359 492 359 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phosphatidylinositol Glycan Class K (Gpi8), Phosphatidylinositol Glycan Class S (PIG-S), Phosphatidylinositol Glycan Class T (PIG-T) </italic>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpi8 </italic>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U</italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 864 870 864 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 1038 1039 1038 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1046 1052 1046 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 905 910 <span type="species:ncbi:4932">yeast</span>
Glycosylphosphatidylinositol (GPI) anchoring is a membrane attachment mechanism for cell surface proteins widely used in eukaryotes. GPI anchor attachment is catalyzed by GPI transamidase (GPIT) complex, which is composed of at least five subunits: Phosphatidylinositol Glycan Class U (PIG-U), Glycosylphosphatidylinositol Anchor Attachment Protein 1 (GAA1), Phosphatidylinositol Glycan Class K (Gpi8), Phosphatidylinositol Glycan Class S (PIG-S), Phosphatidylinositol Glycan Class T (PIG-T) [2-11]. All of the subunits are required for GPIT to function [3,6-8]. Gpi8 is the likely enzymatic component of the GPIT complex and can be cross-linked to proproteins [5,8,12-14]. GAA1 is able to assemble into PIG-U-containing GPIT complexes that are capable of interacting with a proprotein substrate, and this subunit also is critical in GPI recognition by GPIT [15]. PIG-U contains a sequence motif found in yeast and mammalian fatty acid elongases. This motif has been suggested to play a role in recognizing long chain fatty acids in GPI [3], and PIG-T contains endoplasmic reticulum (ER) localization information.
###end p 10
###begin p 11
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GPAA1 </italic>
###xml 276 285 276 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 436 442 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 446 452 446 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 595 617 595 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U, PIG-T and GAA1 </italic>
In a previous study amplification of PIG-U was noted in the bladder cancer, and was found to contribute to an oncogenic phenotype [16]. A recent study showed PIG-T and GPAA1 were overexpressed in breast cancer cell lines and primary tumors and caused malignant transformation in vitro [17]. Genomic amplification and/or DNA copy number gain are common genetic alterations in cancer that lead to the overexpression of oncogenes [18-20]. PIG-U and PIG-T are located at chromosome 20q and GAA1 is located at chromosome 8q, a chromosomal arm with increased copy number in HNSCC [21,22]. To evaluate PIG-U, PIG-T and GAA1 as possible oncogene candidates in HNSCC, we employed real-time PCR and real-time RT-PCR to determine copy number and RNA expression of those genes in primary HNSCCs.
###end p 11
###begin title 12
Results and discussion
###end title 12
###begin title 13
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
Analysis of mRNA expression of GAA1, PIG-T and PIG-U by QRT-PCR
###end title 13
###begin p 14
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U</italic>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 260 272 260 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIG-T </italic>
###xml 276 282 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 450 471 450 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIG-T and PIG-U</italic>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 682 699 682 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mann-Whitney test</italic>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
Overexpression of PIG-U, one of the GPIT subunits, was reported previously in primary bladder cancer and cell lines [16]. By comparing the mRNA expression ratios of the oral mucosa of normal subjects and tumor tissues of HNSCC patients, we were able to assess GAA1, PIG-T and PIG-U expression alteration in a quantitative manner. In this study, 68.75%, 31.25% and 43.75% of HNSCC exhibited higher mRNA expression in comparison to normal controls for GAA1, PIG-T and PIG-U, respectively (Fig 1). In particular, GAA1 showed a significant increase in mRNA expression in HNSCC, 2.11 (95% CI: 1.43, 2.79), in comparison to that in normal controls, 0.43 (95% CI: -0.76, 1.61), p = 0.014 (Mann-Whitney test).
###end p 14
###begin p 15
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGT </italic>
###xml 40 58 40 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGU vs &#946;-Actin</italic>
###xml 91 95 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 97 102 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGT </italic>
###xml 106 111 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGU </italic>
###xml 293 304 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-Actin </italic>
mRNA Expression Ratio of GAA1, PIGT and PIGU vs beta-Actin. The expression differential of GAA1, PIGT and PIGU between normal (health subjects mucosa) and HNSCC was measured by calculating relative fluorescence amplification of transcripts of gene of interests normalized by the corresponding beta-Actin signal. N, normal; T, HNSCC.
###end p 15
###begin title 16
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
Analysis of copy number of GAA1, PIG-T and PIG-U by QPCR
###end title 16
###begin p 17
###xml 166 178 166 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIG-T </italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 316 330 316 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs &#946;-Actin </italic>
###xml 348 349 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 414 419 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 592 598 589 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 631 644 628 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">paired t-test</italic>
###xml 652 653 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 704 709 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
The combination of QPCR and QRT-PCR is a facile approach to detecting gene amplification and over-expression in tumor specimens. To assess whether the copy number of GAA1, PIG-T and PIG-U was altered in HNSCC, we performed QPCR in 28 HNSCC and matched peripheral leukocyte DNA. The relative copy number of each gene vs beta-Actin is shown in Table 1. Overall, a trend of increasing copy number was found in HNSCC. GAA1 copy number was significantly increased in primary HNSCCs, 0.59 (95% CI: 0.50, 0.79), in comparison to peripheral leukocyte DNA, 0.35 (95% CI: 0.30, 0.50), p = 0.001, while PIG-U showed a border line difference (paired t-test). (Fig 2) Taken together, the increased mRNA expression of GAA1 and low level copy number increase in HNSCC may be relevant as a possible contributor to oncogenic transformation in HNSCC.
###end p 17
###begin p 18
###xml 26 38 26 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIG-T </italic>
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
Copy number alteration of GAA1, PIG-T and PIG-U in HNSCC
###end p 18
###begin p 19
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGT </italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGU </italic>
###xml 90 101 90 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIGT </italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIGU </italic>
###xml 263 274 263 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-Actin </italic>
Relative DNA copy number of GAA1, PIGT and PIGU in HNSCC. The copy number differential of GAA1, PIGT and PIGU between paired lymphocytes and HNSCC was measured by calculating relative fluorescence amplification of gene of interest normalized by the corresponding beta-Actin signal using standard curve method. N, normal; T, HNSCC.
###end p 19
###begin p 20
###xml 243 250 243 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEACAM5</italic>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEACAM6 </italic>
###xml 311 324 311 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;N-TCF-1B</italic>
###xml 463 465 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 498 503 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 686 694 <span type="species:ncbi:9606">patients</span>
Many membranous enzymes, receptors, differentiation antigens and other biologically active proteins proved to be bound to the plasma membrane by GPI. Recent studies report that there are increased levels of the GPI-anchored adhesion molecules CEACAM5, CEACAM6 and mesothelin in response to forced expression of DeltaN-TCF-1B, which could contribute to the induction of effecter molecules potentially relevant for tumor invasion in colorectal carcinomas patients [23]. Notably, our data showed that GAA1 copy numbers were much higher in HNSCC than in control white blood cells. This difference was highly significant, which was corresponded to the elevated RNA expression level in HNSCC patients.
###end p 20
###begin title 21
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U</italic>
Clinical associations with copy number alterations in GAA1, PIG-T and PIG-U
###end title 21
###begin p 22
###xml 56 68 56 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1, PIG-T </italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 354 371 354 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mann-Whitney test</italic>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
###xml 407 413 407 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3b</xref>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 631 632 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 635 641 635 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 655 661 655 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U </italic>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 867 873 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 307 315 <span type="species:ncbi:9606">patients</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
To analyze whether clinical factors are associated with GAA1, PIG-T and PIG-U as potential markers, therefore, we further sub-grouped HNSCC patients by gender, race, stage and tumor site. We found that female HNSCC patients had a higher copy number of GAA1, 0.77 (95% CI: 0.63, 0.91), in comparison to male patients 0.58 (95% CI: 0.40, 0.75), p = 0.025 (Mann-Whitney test) (Table 2). In comparison to GAA1, PIG-T showed significant difference of copy number in paired lymphocytes DNA between male and female patients but not in tumor tissue DNA (Table 3b). Neither race nor tumor site was independently associated with GAA1 (Table 2), PIG-T (Table 3) and PIG-U (Table 4) copy number alterations. One might, therefore, speculate that gender might be a factor in the catalysis of GPI anchor attachment. Five out of 28 HNSCCs were located in larynx. We noticed that the PIG-T DNA copy number of laryngeal HNSCC, showed a relatively lower value in comparison to that in the other sites (Table 3), however, we were unable to draw definite conclusions due to limited case numbers. Additionally, no significances were shown among different stages for each gene.
###end p 22
###begin p 23
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1</italic>
The effects of clinical parameters on copy number of GAA1
###end p 23
###begin p 24
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T</italic>
The effects of clinical parameters on copy number of PIG-T
###end p 24
###begin p 25
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U</italic>
The effects of clinical parameters on copy number of PIG-U
###end p 25
###begin title 26
Conclusion
###end title 26
###begin p 27
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
Our data indicate that increasing of copy number and mRNA expression of GAA1 is characteristic for HNSCC and GAA1 play a role for this GPI anchor subunit in HNSCC.
###end p 27
###begin title 28
Methods
###end title 28
###begin title 29
Subjects
###end title 29
###begin p 30
###xml 467 480 467 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink">03-04-11-131d</bold>
###xml 191 197 <span type="species:ncbi:9606">people</span>
Genomic DNA samples from 28 HNSCC tissues and matching lymphocytes were subjected to QPCR analysis. RNA of tissue samples from 16 microdissected HNSCCs and 4 oral mucosal biopsies of healthy people were subjected to QRT-PCR. All samples were collected at the Department of Otolaryngology-Head and Neck Surgery, School of Medicine, The Johns Hopkins University, after appropriate approval was obtained from the Johns Hopkins institutional review board (IRB approval # 03-04-11-131d).
###end p 30
###begin title 31
Cell lines and culture conditions
###end title 31
###begin p 32
###xml 377 378 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 39 44 <span type="species:ncbi:9606">human</span>
DNA and RNA from a virally transformed human cutaneous keratinocyte cell line (HaCaT) were used as standards for QPCR and QRT-PCR. The HaCaT cell line was grown in DMEM media supplemented with 10% FBS and 1% Penicillin-Streptomycin. Media components were obtained from Gibco Invitrogen Corporation (Carlsbad, CA) and cells were incubated at 37degreesC in an atmosphere of 5% CO2/95% relative humidity.
###end p 32
###begin title 33
Quantitative PCR
###end title 33
###begin p 34
###xml 105 115 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin</italic>
###xml 117 130 114 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U, PIG-T </italic>
###xml 134 138 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gaa1</italic>
###xml 140 151 137 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 223 225 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 228 233 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U</italic>
###xml 234 236 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 239 245 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-T </italic>
###xml 249 254 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 302 303 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 583 584 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 854 864 845 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin</italic>
###xml 997 1010 985 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U, PIG-T </italic>
###xml 1014 1019 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 1059 1070 1047 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
A Perkin-Elmer/ABI 7900 thermocycler (Applied Biosystems, CA) was used to perform QPCR amplification for beta-actin, PIG-U, PIG-T and Gaa1. beta-actin primer and probe sequences used previously were employed in this study [24]. PIG-U[16], PIG-T and GAA1 primer and probe sequences were listed in Table 5. Primers were custom made and obtained from Invitrogen (Carlsbad, CA). All TaqMan probes (Applied Biosystems, Foster City, CA) were 5'-FAM and 3'-TAMRA labeled. PCR amplifications were carried out in buffer containing: 16.6 mM ammonium sulfate, 67 mM Trizma (pH 8.8), 2.5 mM MgCl2, 10 mM beta-mercaptoethanol, 0.1% DMSO, 600 nM each of forward and reverse primers, 200 nM TaqMan probe, 0.6 units Platinum Taq polymerase, and 2% ROX reference dye. 500 picograms of DNA were used to amplify the mitochondrial regions whereas 10 ng were used to amplify beta-actin. The real-time PCR reactions were performed in triplicate for each gene. Data analysis was performed using Microsoft Excel software.PIG-U, PIG-T and GAA1 were normalized using the corresponding beta-actin signal.
###end p 34
###begin p 35
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U, PIG-T </italic>
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
PIG-U, PIG-T and GAA1 primer and probe sequences
###end p 35
###begin title 36
Statistical analysis
###end title 36
###begin p 37
###xml 91 104 91 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U, PIG-T </italic>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 242 255 242 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U, PIG-T </italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 360 373 360 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIG-U, PIG-T </italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAA1 </italic>
###xml 604 612 604 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t-tests </italic>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
The major statistical first endpoint in this study was the comparison of the difference in PIG-U, PIG-T and GAA1 quantitative DNA ratio between lymphocytes DNA and tumor tissue DNA in the HNSCC patients. The second endpoint in this study was PIG-U, PIG-T and GAA1 RNA expression differences between HNSCC patients and normal control subjects. Distributions of PIG-U, PIG-T and GAA1 DNA and RNA quantitative ratios were examined graphically using scatter plots and bar plots with logarithmic scales. Log transformation was chosen for these values and the difference taken for statistical analyses. Paired t-tests were used to determine if these changes were significantly different from each other. All statistical computations were performed using the SPSS system (SPSS, Chicago) and all p values reported are two-sided.
###end p 37
###begin title 38
Authors' contributions
###end title 38
###begin p 39
WWJ carried out cell cultures, QRT-PCR, QPCR, conceived the study, participated in its design, and drafted the manuscript. MZ analyzed the data and performed the statistical analysis. ZTZ and HLP critically revised the manuscript. WGJ and ZMG participated in the design of the study. DS conceived the study. BT conceived the study, participated in its design. JAC conceived the study, participated in its design and coordination, and contributed to the final drafting and critical revision of the manuscript. All authors read and approved the final manuscript.
###end p 39
###begin title 40
Acknowledgements
###end title 40
###begin p 41
This investigation was supported by Maryland Cigarette Restitution Fund and NIDCR 1R01DE015939-01 [JC]; NIH Head and Neck SPORE [WHW, WK, DS, and JC]; the Damon Runyon Cancer Research Foundation CI-#9 [JC].
###end p 41
###begin article-title 42
Head and neck cancer
###end article-title 42
###begin article-title 43
PIG-S and PIG-T, essential for GPI anchor attachment to proteins, form a complex with GAA1 and GPI8
###end article-title 43
###begin article-title 44
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins
###end article-title 44
###begin article-title 45
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast Gaa1p is required for attachment of a completed GPI anchor onto proteins
###end article-title 45
###begin article-title 46
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast Gpi8p is essential for GPI anchor attachment onto proteins
###end article-title 46
###begin article-title 47
The affected gene underlying the class K glycosylphosphatidylinositol (GPI) surface protein defect codes for the GPI transamidase
###end article-title 47
###begin article-title 48
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 38 43 <span type="species:ncbi:4932">yeast</span>
Molecular cloning of human homolog of yeast GAA1 which is required for attachment of glycosylphosphatidylinositols to proteins
###end article-title 48
###begin article-title 49
Gaa1p and gpi8p are components of a glycosylphosphatidylinositol (GPI) transamidase that mediates attachment of GPI to proteins
###end article-title 49
###begin article-title 50
###xml 32 56 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The GPI transamidase complex of Saccharomyces cerevisiae contains Gaa1p, Gpi8p, and Gpi16p
###end article-title 50
###begin article-title 51
Two subunits of glycosylphosphatidylinositol transamidase, GPI8 and PIG-T, form a functionally important intermolecular disulfide bridge
###end article-title 51
###begin article-title 52
###xml 20 38 <span type="species:ncbi:5691">Trypanosoma brucei</span>
GPI transamidase of Trypanosoma brucei has two previously uncharacterized (trypanosomatid transamidase 1 and 2) and three common subunits
###end article-title 52
###begin article-title 53
A cell-free assay for glycosylphosphatidylinositol anchoring in African trypanosomes
###end article-title 53
###begin article-title 54
Active site determination of Gpi8p, a caspase-related enzyme required for glycosylphosphatidylinositol anchor addition to proteins
###end article-title 54
###begin article-title 55
Endoplasmic reticulum proteins involved in glycosylphosphatidylinositol-anchor attachment: photocrosslinking studies in a cell-free system
###end article-title 55
###begin article-title 56
A conserved proline in the last transmembrane segment of Gaa1 is required for glycosylphosphatidylinositol (GPI) recognition by GPI transamidase
###end article-title 56
###begin article-title 57
###xml 50 55 <span type="species:ncbi:9606">human</span>
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer
###end article-title 57
###begin article-title 58
###xml 195 200 <span type="species:ncbi:9606">human</span>
Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer
###end article-title 58
###begin article-title 59
Profiling breast cancer by array CGH
###end article-title 59
###begin article-title 60
###xml 57 62 <span type="species:ncbi:9606">human</span>
Identifying and validating causal genetic alterations in human breast cancer
###end article-title 60
###begin article-title 61
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
###end article-title 61
###begin article-title 62
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients
###end article-title 62
###begin article-title 63
Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression
###end article-title 63
###begin article-title 64
Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin
###end article-title 64
###begin article-title 65
Increased mitochondrial DNA content in saliva associated with head and neck cancer
###end article-title 65

